CytoDyn (CYDY) EBITDA (2010 - 2026)
CytoDyn's EBITDA came in at -$6.56 million for fiscal Q1 2027 (quarter ended Aug 31, 2026), compared with -$4.94 million a year earlier.
Powered by 
Analysis
CytoDyn (CYDY) EBITDA (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Aug 31, 2026, CytoDyn reported EBITDA of -$39.85 million; for FY2026 (ended May 31, 2026), it came in at -$38.56 million.
- Going back by fiscal year, EBITDA was $10.09 million in FY2025, -$16.95 million in FY2024, -$38.28 million in FY2023 and -$141.67 million in FY2022.
- The five-year range for quarterly EBITDA is -$78.35 million (fiscal Q4 2022) to $22.57 million (fiscal Q1 2025).
- Business Quant data shows CYDY's EBITDA at -$5.64 million (Q4 2026), -$6.3 million (Q3 2026) and -$21.36 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | 5.89 Bn |
| 10 | CytoDyn | 349.15 Mn | 300.30 Mn | - | -6.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | -6.56 Mn |
| May 31, 2026 | -5.64 Mn |
| Feb 28, 2026 | -6.30 Mn |
| Nov 30, 2025 | -21.36 Mn |
| Aug 31, 2025 | -4.94 Mn |
| May 31, 2025 | -5.00 Mn |
| Feb 28, 2025 | -3.89 Mn |
| Nov 30, 2024 | -3.59 Mn |
| Aug 31, 2024 | 22.57 Mn |
| May 31, 2024 | -6.51 Mn |
| Feb 29, 2024 | -3.00 Mn |
| Nov 30, 2023 | -3.25 Mn |
| Aug 31, 2023 | -4.20 Mn |
| May 31, 2023 | -3.37 Mn |
| Feb 28, 2023 | -3.34 Mn |
| Nov 30, 2022 | -22.53 Mn |
| Aug 31, 2022 | -9.04 Mn |
| May 31, 2022 | -78.35 Mn |
| Feb 28, 2022 | -18.63 Mn |
| Nov 30, 2021 | -24.28 Mn |
API Access
CytoDyn EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=CYDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "CYDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=CYDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();